.Merck trumps earnings requirements, increases purchases expectation on solid need for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Projections as Keytruda Sales Surge BloombergMerck Supply: Pharma Giant Posts Sturdy Outcomes, Yet Expectation Tumbles Short Real estate investor's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps revenue and also purchases expectations in the middle of Keytruda advantage, yet supplies mixed full-year overview MarketWatch.